When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRK - Bellus Health lead drug flunks chronic cough study
Merck & Company Inc.
BELLUS Health (NASDAQ:BLU) craters 79% premarket on robust volume in reaction to unsuccessful results from a Phase 2 clinical trial, RELIEF, evaluating escalating doses of lead candidate BLU-5937 in patients with refractory chronic cough.
More news on: BELLUS Health Inc., Merck & Co., Inc., Healthcare stocks news, Stocks on the move,